Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RezoluteRZLT +9.11%34 FCF Yield % is -14.99 as of Aug. 23, 2026. GuruFocus rates RZLT with a GF Score™ of 34/100. The stock has 1 warning sign investors should review. Among 1,410 Biotechnology companies, Rezolute ranks worse than 61.84% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Rezolute FCF Yield % Related Terms
Rezolute FCF Yield % Historical Data
* Premium members only.
The historical data trend for Rezolute's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Rezolute's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rezolute FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Rezolute's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Rezolute's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rezolute (RZLT) has a FCF Yield % of -14.99 as of Aug. 23, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Rezolute and its competitors. According to the industry distribution chart, Rezolute ranks #872 out of 1410 companies in the Biotechnology industry, placing it in the top 61.8%.
Is Rezolute's FCF Yield % too high?
Rezolute's current FCF Yield % is -14.99. Based on the distribution chart, Rezolute ranks #872 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Rezolute has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Rezolute's FCF Yield % compare to DNA and EIKN?
According to the Biotechnology industry distribution chart, Rezolute ranks #872 out of 1410 companies for FCF Yield %. This places Rezolute in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Rezolute and its competitors. Rezolute's current FCF Yield % is -14.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rezolute stock overvalued right now?
Rezolute (RZLT) has a current FCF Yield % of -14.99. The current FCF Yield % is -14.99. Rezolute's overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Rezolute (RZLT), the current FCF Yield % is -14.99 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
34GF Score
Get the complete analysis for RZLT
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RZLT has been successfully added to your 
